Commonwealth Equity Services, LLC Nova Bay Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 19, 2022	SELL	$0.18 - $0.31 $1,805 - $3,109	-10,030 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$0.61 - $0.97 $6,118 - $9,729	10,030 New	10,030 $6,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $46.1M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.